Evidence map›Paper›PMID 36139108›Full record

ReviewBiomolecules2022

Antibacterial and Antifungal Sesquiterpenoids: Chemistry, Resource, and Activity.

Hang-Ying Li, Wen-Qian Yang, Xin-Zhu Zhou, Fei Shao, Tong Shen, Hui-Ying Guan, Jie Zheng, Li-Ming Zhang

Abstract readReview
In one paragraph

Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Chemical Profiling and Antimicrobial Activity of the Leaf Essential Oil ofInternational journal of molecular sciences · 2026
    Article
  4. Review
  5. Synthesis of α-Santonin Derivatives Linked toAntibiotics (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. International journal of molecular sciences · 2025
    Review
  14. Article
  15. Article
  16. Bioactive Sesquiterpenoids fromPlants (Basel, Switzerland) · 2025
    Article
  17. Synergistic curative effects ofFrontiers in plant science · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hang-Ying LiCollege of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.
Wen-Qian YangCollege of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.
Xin-Zhu ZhouCollege of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.
Fei ShaoCollege of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.
Tong ShenCollege of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.
Hui-Ying GuanCollege of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.
Jie ZhengCollege of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.
Li-Ming ZhangCollege of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious diseases caused by bacteria and fungi are threatening human health all over the world. It is an increasingly serious problem that the efficacies of some antibacterial and antifungal agents have been weakened by the drug resistance of some bacteria and fungi, which makes a great need for new antibiotics. Sesquiterpenoids, with abundant structural skeleton types and a wide range of bioactivities, are considered as good candidates to be antibacterial and antifungal agents. In the past decades, many sesquiterpenoids were isolated from plants and fungi that exhibited good antibacterial and antifungal activities. In this review, the names, source, structures, antibacterial and antifungal degrees, and mechanisms of sesquiterpenoids with antibacterial and antifungal activity from 2012 to 2022 are summarized, and the structure-activity relationship of these sesquiterpenoids against bacteria and fungi is also discussed.

Indexed as

Antifungal AgentsSesquiterpenesAnti-Bacterial AgentsBacteriaFungiHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAntifungal AgentsSesquiterpenesantibacterial activityantifungal activitychemical structuresmechanismsesquiterpenoidsstructure–activity relationship

Identifiers

PMID36139108
PMCPMC9496053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.